Related Experiment Video
Updated: Jan 3, 2026

07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
830
Pulmonary involvement in mixed connective tissue disease.
Chest
|July 1, 1985
Summary
Pulmonary function abnormalities are common in mixed connective tissue disease (MCTD). This study found reduced lung volumes and diffusing capacity, but normal respiratory muscle function in most patients.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Connective Tissue Diseases
Background:
- Mixed Connective Tissue Disease (MCTD) is an autoimmune disorder with overlapping features of systemic lupus erythematosus, scleroderma, and polymyositis.
- Pulmonary involvement is a significant cause of morbidity and mortality in MCTD, but the specific patterns and frequency of lung function abnormalities require further elucidation.
Purpose of the Study:
- To investigate the prevalence and characteristics of pulmonary function abnormalities in patients with MCTD.
- To assess respiratory muscle strength and function in this patient cohort.
Main Methods:
- A cohort of 16 consecutive MCTD patients underwent comprehensive pulmonary function testing.
- Evaluated parameters included spirometry, total lung capacity (TLC), diffusing capacity for carbon monoxide (DCO), static lung compliance (Cst), airway resistance (RAW), and respiratory muscle function tests (PIP, delta PDI).
Main Results:
- The majority of patients exhibited reduced TLC (10/16) and DCO (14/16).
- Abnormalities in static lung compliance (4/9) and frequency dependence of compliance (7/10) were noted.
- Respiratory muscle function, including peak inspiratory pressure (PIP) and delta PDI, was largely preserved, with no significant abnormalities identified.
Conclusions:
- Pulmonary function abnormalities, particularly restrictive patterns and impaired gas exchange, are highly prevalent in MCTD.
- Respiratory muscle strength does not appear to be a primary limiting factor in pulmonary dysfunction in this disease.
- Further research is warranted to explore the specific mechanisms driving these lung abnormalities in MCTD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
Other Pulmonary Disorders
1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K

